Skip to main navigation
Close
Menu
Main navigation
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action
Breadcrumb
Association for Accessible Medicines
Resources
Resources
Share
Find up-to-date information on generics and biosimilars
Filter Resources
Issues
Biosimilar User Fee Act (BsUFA)
Biosimilars
Complex Generics
Drug Approval Process (GDUFA)
Drug Prices
Drug Shortages
Generic Drug Labeling
Generic Supply Chain
IP Issues
Low Income Subsidies (LIS in Part D)
Medicaid
Medicare
NAFTA
Patent Reform
Patient Stories
Pharmaceutical Waste Take Back
Preventing Drug Abuse
Quality
REMS/Sample Acquisition Remedies
State Initiatives
Tariffs
Trade
Transparency
User Fees
Resource Type
Blog
Amicus Brief
Press Release
Infographic
Video
Report
Fact Sheet
Presentation
Report
Feb 20, 2020
| Craig Burton
White Paper: Medicare and Commercial Plans Fail to Get New Generics to Patients
Press Release
Feb 20, 2020
| Rachel Schwartz
Insurers Fail to Get New Generics to America’s Patients
Press Release
Feb 13, 2020
| Rachel Schwartz
Avalere Analysis Finds Medicare Part D Patients Are Paying More For Their Lower-Cost Generics
Press Release
Feb 10, 2020
| Rachel Schwartz
AAM Statement on Resignation of Chip Davis
Press Release
Feb 6, 2020
| Rachel Schwartz
AAM Announces 2020 Associate Members
Press Release
Feb 6, 2020
| Rachel Schwartz
AAM Announces 2020 Board of Directors
Press Release
Feb 5, 2020
| Rachel Schwartz
The Association for Accessible Medicines Wins Public Affairs Council’s Innovations in Public Affairs Award
Press Release
Jan 29, 2020
| Rachel Schwartz
AAM Statement on Signing USMCA into Law
Press Release
Jan 23, 2020
| Rachel Schwartz
AAM Statement on Avalere Analysis of Generic Substitution
Report
Jan 23, 2020
| Craig Burton
White Paper: Sidelined: How Seniors Miss Out On Savings Available Through Generic Substitution
Press Release
Jan 16, 2020
| Rachel Schwartz
AAM Statement on Senate Passage of USMCA Agreement
Blog
Jan 9, 2020
| Karin Hessler
Competition Matters. That’s Why We Need to Further Improve IPR.
Load More
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Access! 2024
GRx+Biosims 2023
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action